Treatment Outcomes of Intravitreal Aflibercept for Uveitic Macular Edema

Enny Oyenirana National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA

https://orcid.org/0000-0002-2302-6727 View further author information

, MD

Sanjeeb Bhandaria National Eye Institute, National Institutes of Health, Bethesda, Maryland, USAView further author information

, MD, PhD,

Ali Amira National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA;b John Sealy School of Medicine, The University of Texas Medical Branch at Galveston, Galveston, Texas, USAView further author information

, BSA,

Matias Soifera National Eye Institute, National Institutes of Health, Bethesda, Maryland, USAView further author information

, MD,

Sunil Bellura National Eye Institute, National Institutes of Health, Bethesda, Maryland, USAView further author information

, MD,

Susan Vitalea National Eye Institute, National Institutes of Health, Bethesda, Maryland, USAView further author information

, PhD, MHS,

H. Nida Sena National Eye Institute, National Institutes of Health, Bethesda, Maryland, USAView further author information

, MD &

Shilpa Kodatia National Eye Institute, National Institutes of Health, Bethesda, Maryland, USACorrespondence[email protected]
View further author information

, MD show all

Treatment Outcomes of Intravitreal Aflibercept for Uveitic Macular Edema

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment Outcomes of Intravitreal Aflibercept for Uveitic Macular Edema

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date